Retraction : Angiopoietin-like 4 confers resistance to hypoxia/serum deprivation-induced apoptosis through PI3K/Akt and ERK1/2 signaling pathways in mesenchymal stem cells (PLoS ONE (2014) 9:1 (e85808) DOI: 10.1371/journal.pone.0085808);Angiopoietin-like 4 confers resistance to hypoxia/serum deprivation-induced apoptosis through PI3K/Akt and ERK1/2 signaling pathways in mesenchymal stem cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hou, Meng ^a,b   Cui, Jinjin ^a,b   Liu, Jingjin ^a,b   Liu, Fang ^a,b   Jiang, Rui ^a,b   Liu, Kai ^a,b   Wang, Yongshun ^a,b   Yin, Li ^a,b   Liu, Wenhua ^a,b   Yu, Bo ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; ANGIOPOIETIN LIKE 4 RECEPTOR; BETA1 INTEGRIN; CASPASE 3; CYTOCHROME C; FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; MALE; MESENCHYMAL STEM CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOPOIETINS; ANIMALS; ANTIGENS, CD29; APOPTOSIS; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; CYTOPROTECTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MITOCHONDRIA; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84908172723     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194448     Document Type: Erratum

References (42)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757. (Pubitemid 43767064)
2. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705. (Pubitemid 32290358)
3. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46. (Pubitemid 36050962)
4. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148. (Pubitemid 38891685)
5. Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, et al. (2008) Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51: 933-943.
6. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201. (Pubitemid 37173705)
7. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, et al. (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25: 2118-2127. (Pubitemid 47258191)
8. Song H, Cha MJ, Song BW, Kim IK, Chang W, et al. (2010) Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 28: 555-563.
9. Mylotte LA, Duffy AM, Murphy M, O'Brien T, Samali A, et al. (2008) Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 26: 1325-1336.
10. Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, et al. (2002) The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol 67: 143-153. (Pubitemid 36775506)
11. Ross RS (2002) The extracellular connections: the role of integrins in myocardial remodeling. J Card Fail 8: S326-331.
12. Copland IB, Lord-Dufour S, Cuerquis J, Coutu DL, Annabi B, et al. (2009) Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 27: 467-477.
13. Song SW, Chang W, Song BW, Song H, Lim S, et al. (2009) Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 27: 1358-1365.
14. Yu X, Cohen DM, Chen CS (2012) miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Stem Cells 30: 956-964.
15. Oike Y, Akao M, Kubota Y, Suda T (2005) Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy. Trends Mol Med 11: 473-479. (Pubitemid 41415727)
16. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, et al. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275: 28488-28493.
17. Belanger AJ, Lu H, Date T, Liu LX, Vincent KA, et al. (2002) Hypoxia upregulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 34: 765-774. (Pubitemid 35205179)
18. Shibata K, Nakayama T, Hirakawa H, Hidaka S, Nagayasu T (2010) Clinicopathological significance of angiopoietin-like protein 4 expression in oesophageal squamous cell carcinoma. J Clin Pathol 63: 1054-1058.
19. Kim SH, Park YY, Kim SW, Lee JS, Wang D, et al. (2011) ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res 71: 7010-7020.
20. Akhter S, Rahman MM, Lee HS, Kim HJ, Hong ST (2013) Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells. Protein Cell 4: 220-230.
21. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, et al. (2010) Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol 177: 2791-2803.
22. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, et al. (2010) Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem 285: 32999-33009.
23. Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, et al. (2011) Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19: 401-415.
24. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
25. Zhu W, Chen J, Cong X, Hu S, Chen X (2006) Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24: 416-425. (Pubitemid 44464811)
26. Chen J, Baydoun AR, Xu R, Deng L, Liu X, et al. (2008) Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells 26: 135-145.
27. Hui AY, Meens JA, Schick C, Organ SL, Qiao H, et al. (2009) Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. J Cell Biochem 107: 1168-1181.
28. Salsmann A, Schaffner-Reckinger E, Kabile F, Plancon S, Kieffer N (2005) A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreading. J Biol Chem 280: 33610-33619. (Pubitemid 41397162)
29. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344-10349. (Pubitemid 32803022)
30. Geng YJ (2003) Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 1010: 687-697.
31. Ingber DE (2002) Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 91: 877-887. (Pubitemid 35373587)
32. Camenisch G, Pisabarro MT, Sherman D, Kowalski J, Nagel M, et al. (2002) ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 277: 17281-17290. (Pubitemid 34967763)
33. Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, et al. (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 162: 1521-1528. (Pubitemid 36512834)
34. Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ, et al. (2011) ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood 118: 3990-4002.
35. Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA (2010) Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angio-poietin-like 4. FASEB J 24: 4648-4659.
36. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, et al. (2005) Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A 102: 6086-6091. (Pubitemid 40594259)
37. Ge H, Yang G, Huang L, Motola DL, Pourbahrami T, et al. (2004) Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem 279: 2038-2045. (Pubitemid 38084475)
38. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
39. Yamada KM, Geiger B (1997) Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 9: 76-85. (Pubitemid 27065112)
40. Xia H, Nho RS, Kahm J, Kleidon J, Henke CA (2004) Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J Biol Chem 279: 33024-33034. (Pubitemid 39014762)
41. Katanasaka Y, Kodera Y, Kitamura Y, Morimoto T, Tamura T, et al. (2013) Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma. Mol Cancer 12: 31.
42. Stapleton CM, Joo JH, Kim YS, Liao G, Panettieri RA Jr, et al. (2010) Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways. Exp Cell Res 316: 507-516.